{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:07:40Z","timestamp":1790698060308,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T00:00:00Z","timestamp":1585958400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1053\/j.semnuclmed.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T19:40:50Z","timestamp":1549568450000},"page":"218-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["90Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT\/CT-Based Dosimetry"],"prefix":"10.1053","volume":"49","author":[{"given":"Etienne","family":"Garin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Edeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0001","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijrobp.2010.08.015","article-title":"Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres","volume":"82","author":"Lau","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2011.07.012","article-title":"Radioembolization for hepatocellular carcinoma","volume":"56","author":"Sangro","year":"2012","journal-title":"J Hepatol"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0003","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/bjc.1994.436","article-title":"Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: A phase I and II study","volume":"70","author":"Lau","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-8278(18)30243-5","volume":"68","author":"Hermann","year":"2018","journal-title":"J Hepatol"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0005","first-page":"168","article-title":"Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with 90Y microspheres: The experience of the National Tumor Institute of Milan","volume":"55","author":"Chiesa","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2967\/jnumed.111.094235","article-title":"99mTc-MAA SPECT\/CT based dosimetry accurately predicts tumour response and survival in HCC patients treated with 90Y-loaded glass microspheres: Preliminary results","volume":"53","author":"Garin","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0007","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/liv.13220","article-title":"High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microsphere radioembolization","volume":"37","author":"Garin","year":"2017","journal-title":"Liver Int"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0008","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2967\/jnumed.117.199752","article-title":"90Y radioembolization for locally advanced hepatocellular carcinoma with portal vein thrombosis: Long-term outcomes in a 185-patient cohort","volume":"59","author":"Abouchaleh","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2017.12.026","article-title":"Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion","author":"Spreafico","year":"2018","journal-title":"J Hepatol"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0010","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0011","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY). Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0012","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium(90) radioembolization for intermediate-advanced hepatocarcinoma: A phase II study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0013","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00259-015-3210-7","article-title":"Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis","volume":"43","author":"Edeline","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0014","first-page":"1782","article-title":"Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: Intra-arterial iodine-131-iodized oil versus medical support","volume":"35","author":"Raoul","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): An open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0016","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: Selective internal radiation therapy versus sorafenib in Asia-pacific patients with hepatocellular carcinoma","volume":"36","author":"Chow","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0017","series-title":"The Impact of Combining Selective Internal Radiation Therapy (SIRT) With Sorafenib on Overall Survival in Patients With Advanced Hepatocellular Carcinoma: The SORAMIC Trial Palliative Cohort","author":"Ricke","year":"2018"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0018","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1470-2045(18)30024-X","article-title":"Negative phase 3 study of 90Y microspheres versus sorafenib in HCC","volume":"19","author":"Garin","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0019","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00259-015-3157-8","article-title":"Clinical impact of 99mTc-MAA SPECT\/CT-based dosimetry in radioembolization of liver malignancies with 90Y-loaded microspheres","volume":"43","author":"Garin","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2967\/jnumed.113.126839","article-title":"The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging","volume":"55","author":"Walrand","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0021","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/MNM.0b013e32834a716b","volume":"32","author":"Garin","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0022","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jvir.2016.12.1221","article-title":"Correlation of technetium-99 m macroaggregated albumin and yttrium-90 glass microsphere biodistribution in hepatocellular carcinoma: A retrospective review of pretreatment single photon emission CT and posttreatment positron emission tomography\/CT","volume":"28","author":"Haste","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0023","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mednuc.2017.02.005","article-title":"Is there a place for nuclear medicine in the radioembolization of liver tumors?","volume":"41","author":"Garin","year":"2017","journal-title":"M\u00e9d Nucl"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0024","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2967\/jnumed.116.175943","article-title":"High impact of preferential flow on 99mTc-MAA and 90Y-loaded microsphere uptake correlation","volume":"57","author":"Garin","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0025","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2967\/jnumed.112.117614","article-title":"99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization","volume":"54","author":"Wondergem","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0026","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00259-014-2784-9","article-title":"(99 m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: A quantitative evaluation in patients treated with (166)Ho-microspheres","volume":"41","author":"Elschot","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0027","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2967\/jnumed.112.112508","article-title":"Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres","volume":"54","author":"Ulrich","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0028","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2967\/jnumed.115.162685","article-title":"Predictive value of 99mTc-MAA SPECT for 90Y-labeled resin microsphere distribution in radioembolization of primary and secondary hepatic tumors","volume":"56","author":"Ilhan","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0029","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/RLU.0b013e31828162e8","article-title":"Evaluation of the response to selective internal radiation therapy in patients with hepatocellular cancer according to pretreatment (99 m)Tc-MAA uptake","volume":"38","author":"Kucuk","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/2191-219X-3-57","article-title":"Post-radioembolization yttrium-90 PET\/CT - part 2: Dose-response and tumor predictive dosimetry for resin microspheres","volume":"25","author":"Kao","year":"2013","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0031","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2018.01.116","article-title":"Prospective trial using internal pair-production positron emission tomography to establish the yttrium-90 radioembolization dose required for response of hepatocellular carcinoma","volume":"101","author":"Chan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0032","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s00259-018-4064-6","article-title":"Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: Significance of pretreatment 11C-acetate and 18F-FDG PET\/CT and posttreatment 90Y PET\/CT in individualized dose prescription","volume":"45","author":"Ho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0033","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2967\/jnumed.110.075861","article-title":"Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: Radiobiologic considerations","volume":"51","author":"Strigari","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0034","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00259-015-3068-8","article-title":"Radioembolization of hepatocarcinoma with (90)Y glass microspheres: Development of an individualized treatment planning strategy based on dosimetry and radiobiology","volume":"42","author":"Chiesa","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00259-013-2395-x","article-title":"Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: A new personalized promising concept","volume":"40","author":"Garin","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2019.01.006_bib0036","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2967\/jnumed.114.145177","article-title":"Personalized dosimetry and intensification concept with 90Y-loaded glass microsphere radioembolization induce prolonged overall survival in hepatocelluar carcinoma patients with portal vein thrombosis","volume":"56","author":"Garin","year":"2015","journal-title":"J Nucl Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299819300121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299819300121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:34:11Z","timestamp":1757543651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299819300121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0001299819300121"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2019.01.006","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"90Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT\/CT-Based Dosimetry","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2019.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}